Profile

Dr. Robyn Gartrell, MD, MS

Johns Hopkins School of Medicine

Contact Details

Johns Hopkins School of Medicine

Edit Your Contact Info

Bio

ROBYN GARTRELL, MD, MS is an Assistant Professor in Department of Oncology, Division of Pediatric Oncology at Johns Hopkins University School of Medicine. Dr Gartrell completed her pediatric hematology/oncology clinical fellowship, postdoctoral research, and first 5 years as faculty at New York Presbyterian / Columbia University Irving Medical Center in New York City. She joined the faculty at Hopkins in January 2024. Dr. Gartrell’s primary research focuses on combination approaches including radiation, chemotherapy and other target agents with immunotherapy to improve response, increase survival and decrease toxicity for children, adolescents and young adults with cancer. Her laboratory uses advances in tumor immunology to develop more effective and more personalized therapies using multiplex platforms and immunogenomics to evaluate the tumor microenvironment and determine which pediatric tumor types, and which patients, will respond to immunotherapy.

Volunteer Bio  


I am a Pediatric Oncologist and early investigator inspired to use advances in the science of tumor immunology to develop more effective and more personalized therapies for children with cancer, especially brain tumors. I am an Assistant Professor of Pediatrics in the Division of Pediatric Hematology/Oncology focusing my career on 75% translational research and 25% clinical medicine. I completed a postdoctoral fellowship in immunooncology and precision medicine (2016-2019) and I completed a Master of Science degree in Patient Oriented Research (MS/POR) in May 2020. In January 2019, I received a KL2 Career Development award focusing my research on tumor immune microenvironment (TIME) in adult brain tumors. Throughout my postdoctoral training and KL2, I sought to enrich my knowledge of immunology in cancer using several state of the art modalities. I have established my laboratory in pediatric immunooncology and precision medicine, with focus on evaluating the TIME in childhood brain tumors using multiplex platforms, single cell analysis and immunogenomics to help determine which combination therapies will improve survival in these devastating cases. In January 2020, I joined SITC's Early Career Scientist Committee.